Oral Ponesimod Versus Teriflunomide In Relapsing MUltiple Sclerosis
Public ClinicalTrials.gov record NCT02425644. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Multicenter, Randomized, Double-blind, Parallel-group, Active-controlled, Superiority Study to Compare the Efficacy and Safety of Ponesimod to Teriflunomide in Subjects With Relapsing Multiple Sclerosis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
International clinical trial to compare ponesimod and teriflunomide in relapsing multiple sclerosis
Study identification
- NCT ID
- NCT02425644
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 1,133 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 55 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 3, 2015
- Primary completion
- May 15, 2019
- Completion
- May 15, 2019
- Last update posted
- Mar 29, 2025
2015 – 2019
United States locations
- U.S. sites
- 10
- U.S. states
- 8
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Investigator Site 8045 | Carlsbad | California | 92011 | — |
| Investigator Site 8311 | Pomona | California | 91767 | — |
| Investigator Site 8036 | Denver | Colorado | 80209 | — |
| Investigator Site 8065 | Ormond Beach | Florida | 32174 | — |
| Investigator Site 8018 | Tampa | Florida | 33612 | — |
| Investigator Site 8013 | Indianapolis | Indiana | 46256 | — |
| Investigator Site 8040 | Raleigh | North Carolina | 27607 | — |
| Investigator Site 8006 | Columbus | Ohio | 43214 | — |
| Investigator Site 8015 | Franklin | Tennessee | 37064 | — |
| Investigator Site 8042 | Orem | Utah | 84058 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 152 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02425644, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 29, 2025 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02425644 live on ClinicalTrials.gov.